VASCULAR BIOGENICS LTD's ticker is and the CUSIP is M96883909. A total of 2 filers reported holding VASCULAR BIOGENICS LTD in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $1 | – | 7,300 | +508.3% | 0.00% | – |
| Q4 2022 | $0 | -100.0% | 1,200 | -99.3% | 0.00% | – |
| Q3 2022 | $26,000 | – | 173,700 | +28850.0% | 0.00% | – |
| Q2 2022 | $0 | -100.0% | 600 | -99.5% | 0.00% | – |
| Q1 2022 | $203,000 | +298.0% | 120,300 | +364.5% | 0.00% | – |
| Q4 2021 | $51,000 | -58.2% | 25,900 | -50.9% | 0.00% | – |
| Q3 2021 | $122,000 | -3.2% | 52,800 | 0.0% | 0.00% | – |
| Q2 2021 | $126,000 | 0.0% | 52,800 | +8241.2% | 0.00% | – |
| Q1 2021 | $126,000 | -47.9% | 633 | -50.7% | 0.00% | – |
| Q4 2020 | $242,000 | +952.2% | 1,283 | +561.3% | 0.00% | – |
| Q3 2020 | $23,000 | +1050.0% | 194 | +921.1% | 0.00% | – |
| Q2 2020 | $2,000 | -33.3% | 19 | -32.1% | 0.00% | – |
| Q1 2020 | $3,000 | +200.0% | 28 | +133.3% | 0.00% | – |
| Q3 2019 | $1,000 | -85.7% | 12 | -77.8% | 0.00% | – |
| Q2 2019 | $7,000 | +16.7% | 54 | -12.9% | 0.00% | – |
| Q4 2018 | $6,000 | -45.5% | 62 | -10.1% | 0.00% | – |
| Q3 2018 | $11,000 | +83.3% | 69 | +137.9% | 0.00% | – |
| Q2 2018 | $6,000 | – | 29 | +26.1% | 0.00% | – |
| Q1 2018 | $0 | -100.0% | 23 | +91.7% | 0.00% | – |
| Q4 2017 | $1,000 | – | 12 | +71.4% | 0.00% | – |
| Q3 2017 | $0 | – | 7 | +40.0% | 0.00% | – |
| Q2 2017 | $0 | -100.0% | 5 | -94.8% | 0.00% | – |
| Q1 2017 | $2,000 | +100.0% | 97 | +470.6% | 0.00% | – |
| Q4 2016 | $1,000 | -50.0% | 17 | -56.4% | 0.00% | – |
| Q2 2016 | $2,000 | – | 39 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SABBY MANAGEMENT, LLC | 198 | $41,000 | 0.01% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GROUP ONE TRADING, L.P. | 67,200 | $138,000 | 0.00% |
| SIMPLEX TRADING, LLC | 52,800 | $122,000 | 0.00% |